Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
05 2022
Historique:
received: 17 09 2019
accepted: 01 04 2021
revised: 24 03 2021
pubmed: 29 4 2021
medline: 14 5 2022
entrez: 28 4 2021
Statut: ppublish

Résumé

Amyotrophic Lateral Sclerosis (ALS) is recognised to be a complex neurodegenerative disease involving both genetic and non-genetic risk factors. The underlying causes and risk factors for the majority of cases remain unknown; however, ever-larger genetic data studies and methodologies promise an enhanced understanding. Recent analyses using published summary statistics from the largest ALS genome-wide association study (GWAS) (20,806 ALS cases and 59,804 healthy controls) identified that schizophrenia (SCZ), cognitive performance (CP) and educational attainment (EA) related traits were genetically correlated with ALS. To provide additional evidence for these correlations, we built single and multi-trait genetic predictors using GWAS summary statistics for ALS and these traits, (SCZ, CP, EA) in an independent Australian cohort (846 ALS cases and 665 healthy controls). We compared methods for generating the risk predictors and found that the combination of traits improved the prediction (Nagelkerke-R

Identifiants

pubmed: 33907316
doi: 10.1038/s41431-021-00885-y
pii: 10.1038/s41431-021-00885-y
pmc: PMC9090723
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

532-539

Informations de copyright

© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.

Références

Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–72.
pubmed: 28700839 doi: 10.1056/NEJMra1603471
van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH et al. Amyotrophic lateral sclerosis. Lancet. 2017. https://doi.org/10.1016/S0140-6736(17)31287-4 .
Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197–206.
pubmed: 27830784 pmcid: 5585017 doi: 10.1038/nature20413
Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatr. 2011;82:623–7.
doi: 10.1136/jnnp.2010.224501
Longinetti E, Mariosa D, Larsson H, Almqvist C, Lichtenstein P, Ye W, et al. Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an early age. Eur J Neurol. 2017;24:137–42.
pubmed: 28000353 doi: 10.1111/ene.13165
Rippon GA, Scarmeas N, Gordon PH, Murphy PL, Albert SM, Mitsumoto H, et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol. 2006;63:345–52.
pubmed: 16533961 doi: 10.1001/archneur.63.3.345
Irwin D, Lippa CF, Swearer JM. Cognition and amyotrophic lateral sclerosis (ALS). Am J Alzheimers Dis Other Demen. 2007;22:300–12.
pubmed: 17712161 doi: 10.1177/1533317507301613
Raaphorst J, de Visser M, Linssen WHJP, de Haan RJ, Schmand B. The cognitive profile of amyotrophic lateral sclerosis: a meta-analysis. Amyotroph Lateral Scler. 2010;11:27–37.
pubmed: 19180349 doi: 10.3109/17482960802645008
Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90.
pubmed: 16116120 doi: 10.1212/01.wnl.0000172911.39167.b6
Yu Y, Su F-C, Callaghan BC, Goutman SA, Batterman SA, Feldman EL. Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan. PLOS ONE. 2014;9:e101186.
pubmed: 24979055 pmcid: 4076303 doi: 10.1371/journal.pone.0101186
Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86:168–73.
pubmed: 24769471 doi: 10.1136/jnnp-2013-307223
Deary IJ, Spinath FM, Bates TC. Genetics of intelligence. Eur J Hum Genet. 2006;14:690–700.
pubmed: 16721405 doi: 10.1038/sj.ejhg.5201588
Krapohl E, Rimfeld K, Shakeshaft NG, Trzaskowski M, McMillan A, Pingault J-B, et al. The high heritability of educational achievement reflects many genetically influenced traits, not just intelligence. PNAS. 2014;111:15273–8.
pubmed: 25288728 pmcid: 4210287 doi: 10.1073/pnas.1408777111
Wingo TS, Cutler DJ, Yarab N, Kelly CM, Glass JD. The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry. PLoS One 2011;6. https://doi.org/10.1371/journal.pone.0027985 .
van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48:1043–8.
pubmed: 27455348 pmcid: 5556360 doi: 10.1038/ng.3622
Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh P-R, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47:1236–41.
pubmed: 26414676 pmcid: 4797329 doi: 10.1038/ng.3406
Bandres-Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G, et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. 2019;85:470–81.
pubmed: 30723964 pmcid: 6450729 doi: 10.1002/ana.25431
McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O’Brien M, Kahn RS et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun. 2017;8. https://doi.org/10.1038/ncomms14774 .
Turley P, Walters RK, Maghzian O, Okbay A, Lee JJ, Fontana MA, et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat Genet. 2018;50:229–37.
pubmed: 29292387 pmcid: 5805593 doi: 10.1038/s41588-017-0009-4
Maier RM, Zhu Z, Lee SH, Trzaskowski M, Ruderfer DM, Stahl EA, et al. Improving genetic prediction by leveraging genetic correlations among human diseases and traits. Nat Commun. 2018;9:989.
pubmed: 29515099 pmcid: 5841449 doi: 10.1038/s41467-017-02769-6
Maier R, Moser G, Chen G-B, Ripke S, Cross-Disorder Working Group of the Psychiatric Genomics Consortium, Coryell W, et al. Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder. Am J Hum Genet. 2015;96:283–94.
pubmed: 25640677 pmcid: 4320268 doi: 10.1016/j.ajhg.2014.12.006
Zheng J, Erzurumluoglu AM, Elsworth BL, Kemp JP, Howe L, Haycock PC, et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics. 2017;33:272–9.
pubmed: 27663502 doi: 10.1093/bioinformatics/btw613
Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord. 2000;1:293–9.
doi: 10.1080/146608200300079536
Sachdev PS, Lammel A, Trollor JN, Lee T, Wright MJ, Ames D, et al. A comprehensive neuropsychiatric study of elderly twins: the older Australian twins study. Twin Res Hum Genet. 2009;12:573–82.
pubmed: 19943720 doi: 10.1375/twin.12.6.573
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:1–16.
doi: 10.1186/s13742-015-0047-8
Consortium the HR. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48:1279–83.
doi: 10.1038/ng.3643
The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526:68–74.
doi: 10.1038/nature15393
Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88:76–82.
pubmed: 21167468 pmcid: 3014363 doi: 10.1016/j.ajhg.2010.11.011
Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J, Schizophrenia Working Group of the Psychiatric Genomics Consortium. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47:291–5.
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268. e6
pubmed: 29566793 pmcid: 5867896 doi: 10.1016/j.neuron.2018.02.027
The International HapMap 3 Consortium. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52–58.
pmcid: 3173859 doi: 10.1038/nature09298
R: the R project for statistical computing. https://www.r-project.org/ (accessed 29 Jan2020).
Nakazawa M fmsb: functions for Medical Statistics Book with some Demographic Data. 2019 https://CRAN.R-project.org/package=fmsb (accessed 29 Jan 2020).
Balding DJ, Moltke I, Marioni J. Handbook of Statistical Genomics Fourth Edition. John Wiley & Sons, New Jersey, 2019.
Robinson MR, Kleinman A, Graff M, Vinkhuyzen AAE, Couper D, Miller MB, et al. Genetic evidence of assortative mating in humans. Nat Hum Behav. 2017;1:0016.
doi: 10.1038/s41562-016-0016
Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort profile: the health and retirement study (HRS). Int J Epidemiol. 2014;43:576–85.
pubmed: 24671021 pmcid: 3997380 doi: 10.1093/ije/dyu067
Marquez-Luna C, Gazal S, Loh P-R, Furlotte N, Auton A, Team 23andMe Research et al. Modeling functional enrichment improves polygenic prediction accuracy in UK Biobank and 23andMe data sets. e-pub preprint bioRxiv 2018: 375337. https://doi.org/10.1101/375337 .
Gazal S, Finucane HK, Furlotte NA, Loh P-R, Palamara PF, Liu X, et al. Linkage disequilibrium–dependent architecture of human complex traits shows action of negative selection. Nat Genet. 2017;49:1421–7.
pubmed: 28892061 pmcid: 6133304 doi: 10.1038/ng.3954
Lloyd-Jones LR, Zeng J, Sidorenko J, Yengo L, Moser G, Kemper KE, et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat Commun. 2019;10:1–11.
doi: 10.1038/s41467-019-12653-0
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 2018;50:1112.
pubmed: 30038396 pmcid: 6393768 doi: 10.1038/s41588-018-0147-3
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
pmcid: 4112379 doi: 10.1038/nature13595
Pardiñas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381–9.
pubmed: 29483656 pmcid: 5918692 doi: 10.1038/s41588-018-0059-2
Trampush JW, Yang MLZ, Yu J, Knowles E, Davies G, Liewald DC, et al. GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium. Mol Psychiatry. 2017;22:336–45.
pubmed: 28093568 pmcid: 5322272 doi: 10.1038/mp.2016.244
Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, Mora G. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10:205–9.
pubmed: 19267274 doi: 10.1080/17482960902721634
Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79:1970–4.
pubmed: 22955124 pmcid: 4098841 doi: 10.1212/WNL.0b013e31826daf50
Weisskopf MG, O’Reilly EJ, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, et al. Prospective study of military service and mortality from ALS. Neurology. 2005;64:32–37.
pubmed: 15642900 doi: 10.1212/01.WNL.0000148649.17706.D9
Visser AE, Rooney JPK, D’Ovidio F, Westeneng H-J, Vermeulen RCH, Beghi E et al. Multicentre, cross-cultural, population-based, case–control study of physical activity as risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018: jnnp-2017-317724.
Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S, et al. Lifestyle factors and risk of amyotrophic lateral sclerosis: a case-control study in Japan. Ann Epidemiol. 2009;19:359–64.
pubmed: 19342254 doi: 10.1016/j.annepidem.2009.01.015
Harwood CA, Westgate K, Gunstone S, Brage S, Wareham NJ, McDermott CJ, et al. Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:377–84.
pubmed: 26998882 pmcid: 4950417 doi: 10.3109/21678421.2016.1154575
Rheenen W, van, Peyrot WJ, Schork AJ, Lee SH, Wray NR. Genetic correlations of polygenic disease traits: from theory to practice. Nat Rev Genet. 2019;20:567–81.
pubmed: 31171865 doi: 10.1038/s41576-019-0137-z
Chatterjee N, Wheeler B, Sampson J, Hartge P, Chanock SJ, Park J-H. Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet. 2013;45:400–5.
pubmed: 23455638 pmcid: 3729116 doi: 10.1038/ng.2579
Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668–81.
pubmed: 29700475 pmcid: 5934326 doi: 10.1038/s41588-018-0090-3

Auteurs

Restuadi Restuadi (R)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Fleur C Garton (FC)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Beben Benyamin (B)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Australian Centre for Precision Health, University of South Australia Cancer Research Institute, School of Health Sciences, University of South Australia, Adelaide, SA, Australia.

Tian Lin (T)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Kelly L Williams (KL)

Centre for MND Research, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.

Anna Vinkhuyzen (A)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Wouter van Rheenen (W)

UMC Utrecht Brain Center Rudolf Magnus, Utrecht, Netherlands.

Zhihong Zhu (Z)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Nigel G Laing (NG)

Centre for Medical Research, University of Western Australia, Nedlands, WA, Australia.
Harry Perkins Institute of Medical Research, Nedlands, WA, Australia.

Karen A Mather (KA)

Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Neuroscience Research Australia Institute, Randwick, NSW, Australia.

Perminder S Sachdev (PS)

Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Neuropsychiatric Institute, The Prince of Wales Hospital, UNSW, Randwick, NSW, Australia.

Shyuan T Ngo (ST)

Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, Australia.
Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.

Frederik J Steyn (FJ)

Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.
School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.

Leanne Wallace (L)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Anjali K Henders (AK)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.

Peter M Visscher (PM)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.

Merrilee Needham (M)

Fiona Stanley Hospital, Perth, WA, Australia.
Notre Dame University, Fremantle, WA, Australia.
Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.

Susan Mathers (S)

Calvary Health Care Bethlehem, Parkdale, VIC, Australia.

Garth Nicholson (G)

Centre for MND Research, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.
ANZAC Research Institute, Concord Repatriation General Hospital, Sydney, NSW, Australia.

Dominic B Rowe (DB)

Centre for MND Research, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.

Robert D Henderson (RD)

Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, Australia.
Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

Pamela A McCombe (PA)

Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.
Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

Roger Pamphlett (R)

Discipline of Pathology and Department of Neuropathology, Brain and Mind Centre, The University of Sydney, Sydney, NSW, Australia.

Ian P Blair (IP)

Centre for MND Research, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.

Naomi R Wray (NR)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.

Allan F McRae (AF)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia. a.mcrae@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH